Premium
Anthralin Therapy for Alopecia Areata
Author(s) -
Nelson Dan A.,
Spielvogel RichardL.
Publication year - 1985
Publication title -
international journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 93
eISSN - 1365-4632
pISSN - 0011-9059
DOI - 10.1111/j.1365-4362.1985.tb05589.x
Subject(s) - alopecia areata , medicine , dermatology , irritant contact dermatitis , contact dermatitis , regimen , alopecia universalis , therapeutic effect , surgery , allergy , immunology
Topical anthralin application producing a brisk irritant contact dermatitis has been reported to have therapeutic benefit in alopecia areata. A pilot clinical study was undertaken to determine whether topical anthralin application in doses low enough to produce only minimal contact dermatitis would produce a similar therapeutic response. None of the patients in the study received any benefit from this low‐dose regimen. If anthralin is of benefit in the therapy of alopecia areata, a significant irritant contact dermatitis is apparently required.